Sex-specific clinical differences in cluster headache: A systematic review and meta-analysis
Abstract
Objective: Sex-related differences in cluster-headache (CH) have been reported with inconsistent findings across studies. This systematic review and meta-analysis aimed to reveal sex differences in clinical features, attack characteristics, autonomic symptoms, associated features, and comorbidities in patients with CH.
Methods: This study was conducted accordance to PRISMA guidelines. Observational studies reporting clinical features in both sexes among patients diagnosed with CH were identified through searches of PubMed, Embase, Scopus, and Web of Science up to July 2025. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS), and studies with NOS scores≥ 7 were included in the quantitative meta-analysis. Pooled odds ratios (OR) and mean differences were calculated using a random-effects model.
Results: Nineteen high-quality studies were included. No significant sex differences were found in age-at-onset, attack duration and attack frequency, pain intensity, attack lateralization or diurnal and annual rhythmicity. Most cranial autonomic symptoms were comparable between sexes, although eyelid edema (OR=1.94, CI=1.62-2.33) was more frequently observed in females who had also higher rates of migraine (OR=2.72, CI=2.58-2.88) and psychiatric comorbidities (OR=1.73, CI=1.32-2.27) and were less likely to smoke (OR=0.33, CI=0.16-0.69) or consume alcohol (OR=0.32, CI=0.15-0.69).
Conclusions: This meta-analysis suggests that CH has a largely similar clinical…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.